BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects
Clinical trial NCT05418803 · COMPLETED
Trial details
- NCT number
- NCT05418803
- Sponsor
- Yuhan Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-28
- Primary completion
- 2020-02-14
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.